XML 93 R8.htm IDEA: XBRL DOCUMENT v2.4.0.8
Consolidated Statements of Cash Flows (USD $)
In Millions, unless otherwise specified
12 Months Ended
Jun. 30, 2013
Jun. 30, 2012
Jun. 30, 2011
Cash flows from operating activities:      
Net earnings $ 334 $ 1,069 $ 959
Loss from discontinued operations, net of tax 1 1 7
Earnings from continuing operations 335 1,070 966
Adjustments to reconcile earnings from continuing operations to net cash provided by operating activities:      
Depreciation and amortization 397 325 313
Gain on sale of investment in CareFusion 0 0 (75)
Impairments and loss on disposal of assets 859 21 9
Share-based compensation 93 85 80
Provision for deferred income taxes 21 158 128
Provision for bad debts 31 22 27
Change in fair value of contingent consideration obligation 0 (71) (7)
Change in operating assets and liabilities, net of effects from acquisitions:      
Decrease/(increase) in trade receivables 216 (129) (457)
Increase in inventories (370) (495) (665)
Increase in accounts payable 426 319 1,356
Other accrued liabilities and operating items, net (281) (129) (280)
Net cash provided by operating activities 1,727 1,176 1,395
Cash flows from investing activities:      
Acquisition of subsidiaries, net of cash acquired (2,239) (174) (2,300)
Additions to property and equipment (195) (263) (291)
Purchase of held-to-maturity securities and other investments (12) (35) (156)
Proceeds from sale of property and equipment 0 3 3
Proceeds from maturities of held-to-maturity securities 71 92 10
Proceeds from sale of CareFusion common stock 0 0 706
Net cash used in investing activities (2,375) (377) (2,028)
Cash flows from financing activities:      
Payment of contingent consideration obligation (4) 0 (10)
Net change in short-term borrowings (1) 13 46
Reduction of long-term obligations (305) (251) (229)
Proceeds from long-term obligations, net of issuance costs 1,286 496 495
Net proceeds from issuance of common shares 121 42 63
Tax disbursements from share-based compensation (19) (4) (14)
Dividends on common shares (353) (300) (274)
Purchase of treasury shares (450) (450) (270)
Net cash provided by/(used in) financing activities 275 (454) (193)
Net increase/(decrease) in cash and equivalents (373) 345 (826)
Cash and equivalents at beginning of period 2,274 1,929 2,755
Cash and equivalents at end of period 1,901 2,274 1,929
Cash payments for interest 128 118 116
Cash payments for income taxes $ 899 $ 513 $ 588